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expired were those who developed cerebritis, meningitis or
brain abscess.
Conclusion: Mucormycosis is a rare but usually fatal fungal
infection. High index of suspicion, early diagnosis, and
combination treatment with antifungal agents and surgical
debridement may improve the prognosis of this serious
infection. Resistance to amphotericin B is increasing in
mucoral agents. Mocurmycosis has a good response to
posaconazole.
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Background: The morbidity and mortality rates are
signiﬁcantly increased in immunodepressed patients as a
result of severe fungal infections. The present study aimed
to conduct a retrospective investigation of the etiology of
fungal infections in a group of immunodepressed patients.
Methods: The authors have retrospectively analyzed
the hospital records of 79 immunodepressed patients
(44 males, 35 females) admitted at the Department
of Infectious Diseases from Timisoara. The positive
diagnosis was established based on physical examination
(fever, weight loss, white depots on tongue, headache,
anorexia, asthenia) and laboratory data (leukocyte count,
erythrocyte sedimentation rate, C reactive protein, titre
of antistreptolysin O antibodies, electrophoresis, blood
culture, sputum culture, ELISA, Western blot, glossal
exudate and CHROM-AGAR or Sabouraud medium culture).
The identiﬁcation has been made by API Candida system,
ATB Fungus 2 system testing for antifungal sensibility and
direct microscopy examination of fungal specimens. The
data obtained was statistically processed with EpiInfo 5
program.
Results: The study group was distributed as follows:
16 patients had diabetes mellitus, 24 had chronic hepatitis,
12 had liver cirrhosis, 12 had hematological malignancies,
6 had pulmonary tuberculosis, 5 had breast cancer and 4
had pulmonary cancer. Fungal infections were diagnosed in
65 patients (82.27%): 50 patients (76.92%) presented glossal
candidiasis, 12 (18.46%) had oropharingeal candidiasis, and
3 (4.61%) had esophageal candidiasis. There have been
isolated 40 strains of Candida albicans and 25 strains of
Candida non-albicans (p = 0.03) among which 10 strains of
Candida glabrata, 9 strains of Candida keﬁr and 6 strains
of Candida parapsilosis. Out of the 40 strains of Candida
albicans, 26 were resistant to ﬂuconazole (p = 0.04) but all
were sensitive to itraconazole.
Conclusion: The knowledge of the etiological spectrum of
fungal infections in immunocompromised patients allows
the proper implementation of the antifungal treatment and
prophylaxis measures thus leading to satisfying results.
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Background: The incidence of the life-threatening invasive
fungal infection, Zygomycosis, has been increasing over
the past two decades. Cutaneous Zygomycosis represents
the third most common type, following Rhinocerebral
and Pulmonary forms. It can be superﬁcial, invasive or
disseminated. Primary and isolated Scalp involvement is
very rare.
Method: We report a case of scalp Zygomycosis in a diabetic
patient presented with large eschar. He was treated by
surgical excision, skin graft and antifungal therapy using
Amphotericin B lipid complex for one month followed by
Posaconazole for three months.
Results: He was successively cured with no evidence of
recurrence for one year.
Conclusion: Cutaneous Zygomycosis requires high index of
clinical suspicion for timely diagnosis through early skin
biopsy for histopathology and culture particularly if there
is a skin necrosis. Treatment consists of combination of
prompt surgical intervention and antifungal therapy.
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Aim: To establish a murine model of invasive pulmonary
aspergillosis and to analyze its reserch value.
Methods: Mice were immunosuppressed with cyclosphos-
phamide by intraperitoneal injections and in the process
routine blood test were monitored. Invasive pulmonary
aspergillosis was induced by inoculation of Aspergillus
fumigatus spore suspension with self-made tracheal
intubation. Mice were sacriﬁced on day 1, 3, 5, 7 after
inoculation and their lung tissues were was cultured and
histopathologically analyzed.
Results: Mice shows a loss of weight and depression after
a series of different dose of cyclosphosphamide injection.
Routine blood test shows a signiﬁcant decrease of white
blood cells. Nutrogranulocytes and lymphocytes can’t be
distinguished. By observing pathological slices, we can
see lung tissue lesion aggrates gradually after inoculation.
Haemorrhage and cellulose exsudation is obviously seen;
sporus aggregat and germinate. As a result, alveoli are
destroyed diffusely and a large area of lung edema
happened.
Conclusions: A murine model of invasive pulmonary
aspergillosis is succes sfully established, which will de a
reference of further studies of aspergillosis pathogenesis
and pathophysiology, in addition to antifungal agent
pharmacodynamics.
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Mucormycosis invasive fungal infection affecting any
organ. Over 50% of cases are rhinocerebral involvement
requiring emergent, aggressive, disﬁguring facial surgery.
Mucormycosis affects immunocompromised patients or
those with metabolic abnormalities.
51yo woman presented with lethargy, decreased PO intake
for 5 days. PMH: DM, HTN (both non-compliant), CVA, PE,
DVT, IVC ﬁlter.
Patient underwent procedure for dental abscess in right
maxilla 5 days before admission, was on amoxicillin, denied
recent fevers, chills. She hasn’t been taking insulin for
unknown time.
On examination: right-sided facial swelling, numbness, right
eye closed with surrounding erythema, proptosis, diplopia,
decreased visual acuity. Nasal mucosa didn’t reveal black
turbinates.
